April 15 (Reuters) - Acasti Pharma Inc ACST.V :
* ACASTI PHARMA ANNOUNCES TRILOGY 1 TRIAL HAS ACHIEVED 100% PATIENT RANDOMIZATION IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA
* ACASTI PHARMA INC - TOP LINE RESULTS REMAIN ON TRACK FOR YEAR-END
* ACASTI PHARMA INC - ANNUAL PERFORMANCE GRANTS OF STOCK OPTIONS AND AMENDMENT OF STOCK OPTION PLAN ANNOUNCED